Finally, we provide an outlook on recent perspectives on deciphering the underlying pathophysiological mechanisms of leptin-mediated cardiomyopathy and future therapeutic approaches for the treatment of diabetes-mediated cardiovascular disease. Here, LEP is linked to cardiomyopathy.